The in-person event will take place in Brussels, Belgium on October 11th.

The congress is targeted towards all professionals involved in the prevention, treatment and diagnosis of rare diseases and orphan drug research and development, including researchers, clinicians, pharma,policy makers and patient representatives.

The program includes the sessions: tackling delay in diagnostics; newborn screening & improvement of prevention; the impact of patient organisations; pricing of Orphan drugs and true cost of illness; regulatory & access challenges in orphan drugs.

Read more info here: